Combination of everolimus and exemestane reduces spread of cancer in the bone

[News]

Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.

More... (http://www.news-medical.net/news/20120323/Combination-of-everolimus-and-exemestane-reduces-spread-of-cancer-in-the-bone.aspx)